drugset / Trial / NCT00108394

Osteopenia and Renal Osteodystrophy: Evaluation and Management

NCT00108394 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to demonstrate whether pamidronate will preserve or increase bone mass in patients with adynamic bone disease, caused by low bone turnover.

Timeline

Start
2002-10
Primary completion
—
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Pamidronate Small molecule — Intravenous